Therapeutic potential of cyclic nucleotide phosphodiesterase inhibitors in heart failure

Expert Opinion on Investigational Drugs

Volumn 9, Issue 5, 2000, Pages 963-973

  Movsesian, M A ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

CAMP; Cardiomyopathy; Cyclic nucleotide phosphodiesterases; Dilated; Heart failure; Inotropy; Myocardium

Indexed keywords

AMRINONE; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; ENOXIMONE; ENZYME INHIBITOR; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; MILRINONE; PHOSPHOLAMBAN;

CARDIOMYOPATHY; HEART FAILURE; HEART MUSCLE; HUMAN; INOTROPISM; MUSCLE CELL; NONHUMAN; REVIEW;

EID: 0034014939     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.9.5.963     Document Type: Review

References (85)